Imipenem and Cilastatin (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Imipenem and Cilastatin drug offered from Fresenius Kabi USA, LLC. This Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Imipenem and Cilastatin Sodium |
| SUBSTANCE NAME: | IMIPENEM; CILASTATIN SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2012-01-03 |
| END MARKETING DATE: | 0000-00-00 |
Imipenem and Cilastatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Imipenem and Cilastatin from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500; 500(mg/20mL; mg/20mL) |
| START MARKETING DATE: | 2012-01-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-322_b9f1412f-71b8-4b8d-af14-1fc9eb8c6ea6 |
| PRODUCT NDC: | 63323-322 |
| APPLICATION NUMBER: | ANDA090577 |
Other IMIPENEM; CILASTATIN SODIUM Pharmaceutical Manufacturers / Labelers:
